https://www.selleckchem.com/peptide/pmx-205.html
1 ± 20,854.9 vs. 18,739.1 ± 12,258.7, respectively; P 0.001) and background liver iron deposition analyses (35,554.7 ± 19,854.8 vs. 17,292.4 ± 11,605.8, respectively; P 0.001). Tumor size (P = 0.005), etiology (P = 0.001), and degree of fibrosis (P = 0.042) were significantly associated with the presence of a PTHR. A PTHR in HCCs on T2*WIs was strongly associated with peritumoral iron deposition in the iron-deposited background liver but not with the fibrous capsule. A PTHR in HCCs on T2*WIs was strongly associated with peritum